Reckitt CFO Day departs
This article was originally published in The Tan Sheet
Executive SummaryColin Day, Reckitt Benckiser's chief financial officer for 10 years, will leave the organization, the U.K. company says Oct. 22. Day, who as CFO has seen the firm significantly expand its pharmaceutical business, will remain in the position until March 2011 to ensure a smooth transition. A successor will be announced in the next few months, the firm said
You may also be interested in...
Full, planned acquisition of Tokyo-based operation will give US biotech giant a firmer foothold in key market and new platform for Otezla growth.
Quanta Dialysis is linking up with B. Braun Avitum UK to support patients with Quanta’s personal hemodialysis device in the home. See what Quanta CEO John Milad said about it here.